Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: A 10-year trend of replacement and expansion

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 321-328

  Mera, Robertino M ^a   Suaya, Jose A ^a   Amrine Madsen, Heather ^a   Hogea, Cosmina S ^a   Miller, Linda A ^a   Lu, Emily P ^a   Sahm, Daniel F ^b   O'Hara, Patrick ^a   Acosta, Camilo J ^a  

^a GLAXOSMITHKLINE   (United States)

^b Eurofins Medinet Inc   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; COMMUNITY ACQUIRED PNEUMONIA; DATA BASE; FEMALE; GENOTYPE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COMMUNITY-ACQUIRED INFECTIONS; DATABASES, FACTUAL; FEMALE; GENTAMICINS; HOSPITALIZATION; HUMANS; INFANT; INPATIENTS; LONGITUDINAL STUDIES; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PHENOTYPE; POPULATION SURVEILLANCE; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UNITED STATES;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 79957639894     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0193     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. 2004. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470-485.
2. Clinical and Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Delorme, T., S. Rose, J. Senita, C. Callahan, and P. Nasr. Epidemiology and susceptibilities of methicillinresistant Staphylococcus aureus in Northeastern Ohio. Am. J. Clin. Pathol. 132:668-677.
4. Dennison, C., and R. Pokras. 2000. Design and operation of the National Hospital Discharge Survey: 1988 redesign. Vital Health Stat. 39:1-42.
5. Edelsberg, J., C. Taneja, M. Zervos, N. Haque, C. Moore, K. Reyes, J. Spalding, J. Jiang, and G. Oster. 2009. Trends in US hospital admissions for skin and soft tissue infections. Emerg. Infect. Dis. 15:1516-1518.
6. Filice, G.A., J.A. Nyman, C. Lexau, C.H. Lees, L.A. Bockstedt, K. Como-Sabetti, L.J. Lesher, and R. Lynfield. 2010. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect. Control Hosp. Epidemiol. 31:365-373.
7. Finelli, L., A. Fiore, R. Dhara, L. Brammer, D.K. Shay, L. Kamimoto, A. Fry, J. Hageman, R. Gorwitz, J. Bresee, and T. Uyeki. 2008. Influenza-Associated Pediatric Mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122:805-811.
8. Francis, J.S., M.C. Doherty, U. Lopatin, C.P. Johnston, G. Sinha, T. Ross, M. Cai, N.N. Hansel, T. Perl, J.R. Ticehurst, K. Carroll, D.L. Thomas, E. Nuermberger, and J.G. Bartlett. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40:100-107.
9. Fridkin, S.K., J.C. Hageman, M. Morrison, L.T. Sanza, K. Como-Sabetti, and J.A. Jernigan. 2005. Methicillin resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
10. Fridkin, S.K., J.R. Edwards, F.C. Tenover, R.P. Gaynes, and J.E. McGowan. 2001. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital acquired infections. Clin. Infect. Dis. 33:324-330.
11. Gerber, J.S., S.E. Coffin, S.A. Smathers, and T.E. Zaoutis. Trends in the incidence of Methicillin-Resistant Staphylococcus aureus infection in Children's Hospitals in the United States. Clin. Infect. Dis. 49:65-71.
12. Gonzalez, B.E., A.M. Rueda, S.A. Shelburne, D.M. Musher, R.J. Hamill, and K.G. Hulten. 2006. Communityassociated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect. Control Hosp. Epidemiol. 27:1051-1056. (Pubitemid 44670980)
13. Grundmann, H., M. Aires-de-Souza, J. Boyce, and E. Tiemersma. Emergence and resurgence of meticillinresistant Staphylococcus aureus as a public-health threat. Lancet 638:874-885.
14. Hermos, C.R., R. Shiau, M. Hsiang, H.F. Chambers, and E. Pan. 2009. Epidemiology of community-associated methicillin-resistant Staphylococcus aureus in San Francisco children. J. Pediatr. Infect. Dis. 4:247-259.
15. Jevons, M.P. 1961. "Celbenin"-resistant Staphylococci. BMJ 1:124-125.
16. Kallen, A.J., Y. Mu, S. Bulens, A. Reingold, S. Petit, K. Gershman, S.M. Ray, L.H. Harrison, R. Lynfield, G. Dumyati, J. Townes, W. Schaffner, P.R. patel, S.K. Fridkin. Health care-associated invasive MRSA infections, 2005-2008. JAMA 304:641-648.
17. King, M.D., B.J. Humphrey, Y.F. Wang, E.V. Kourbatova, S.M. Ray, and H.M. Blumberg. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309-317. (Pubitemid 46768185)
18. Klein, E., D.L. Smith, and R. Laxminarayan. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg. Infect. Dis. 13:1840-1846. (Pubitemid 350248484)
19. Klein, E., D.L. Smith, and R. Laxminarayan. 2009. Community-associated Methicilin Resistant Staphylococcus aureus in outpatients, United States 1999-2006. Emerg. Infect. Dis. 15:1925-1030.
20. Klevens, R.M., M.A. Morrison, S.K. Fridkin, A. Reingold, S. Petit, K. Gershman, S. Ray, L.H. Harrison, R. Lynfield, G. Dumyati, J.M. Townes, A.S. Craig, G. Fosheim, L.K. McDougal, and F.C. Tenover. 2006. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg. Infect. Dis. 12:1991-1993. (Pubitemid 44904946)
21. Kuehnert, M.J., H.A. Hill, B.A. Kupronis, J.I. Tokars, S.L. Solomon, and D.B. Jernigan. 2005. Methicillin-resistant Staphylococcus aureus Hospitalizations, United States. Emerg. Infect. Dis. 11:868-872. (Pubitemid 40720847)
22. Leclercq, R. 2009. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin. Microbiol. Infect. 15:224-231.
23. Lowy, F.D. 1998. Staphylococus aureus infections. N. Engl. J. Med. 339:520-532.
24. Moran, G.J., A. Krishnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, R.B. Carey, and D.A. Talan. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
25. Naimi, T.S., K.H. LeDell, K. Como-Sabetti, S.M. Borchardt, D.J. Boxrud, J. Etienne, S.K. Johnson, F. Vandenesch, S. Fridkin, C. O'Boyle, R.N. Danilam, and R. Lynfield. 2003. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984. (Pubitemid 37505530)
26. Noskin, G.A., R.J. Rubin, J.J. Schentag, J. Kluytmans, E.C. Hedblom, M. Smulders, E. Lapetina, and E. Gemmen. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 nationwide inpatient sample database. Arch. Intern. Med. 165:1756-1761.
27. Ollendorf, D.A., A.M. Fendrick, K. Massey, G.R. Williams, and G. Oster. 2002. Is sepsis accurately coded on hospital bills? Value Health 5:79-81. (Pubitemid 34274865)
28. Popovich, K., B. Hota, T. Rice, A. Aroutcheva, and R.A. Weinstein. 2007. Phenotypic prediction rule for communityassociated methicillin-resistant Staphylococcus aureus? J. Clin. Microbiol. 45:2293-2295. (Pubitemid 47203812)
29. Seybold, U., E.V. Kourbatova, J.G. Johnson, S.J. Halvosa, Y.F. Wang, M.D. King, S.M. Ray, and H.M. Blumberg. Emergence of community-associated methicillinresistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42:647-656.
30. Stevens, D.L., A.L. Bisno, H.F. Chambers, E.D. Everett, P. Dellinger, E.J.C. Goldstein, S.L. Gorbach, J.V. Hirschmann, E.L. Kaplan, J.G. Montoya, and J.C. Wade. 2005. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 41:1373-1406. (Pubitemid 41581713)
31. Strausbaugh, L.J., K.B. Crossley, B.A. Nurse, and L.D. Thrupp. 1996. Antimicrobial resistance in long-term-care facilities. Infect. Control Hosp. Epidemiol. 17:129-140. (Pubitemid 126478050)
32. Styers, D., D.J. Sheehan, P. Hogan, and D.F. Sahm. 2006. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5:2.
33. Tenover, F.C., and R.V. Goering. 2009. Methicillin-Resistant Staphylococcus aureus strain USA300: origin and epidemiology. J. Antimicrob. Chemother. 64:441-446.
34. Tattevin, P., L. Basuino, and H.F. Chambers. 2009. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res. Microbiol. 160:187-192.